Workflow
ST凯利:公司海外销售产品包含椎体微创业务产品、创伤类或脊柱类骨科植入物产品等
Mei Ri Jing Ji Xin Wen·2025-11-13 13:42

Core Viewpoint - The company ST凯利 reported that its overseas revenue for the fiscal year 2024 is approximately 219.11 million yuan, accounting for 22.26% of its total revenue for the same period [1]. Group 1: Revenue and Profitability - The overseas market revenue for ST凯利 in 2024 is 219,114,693.56 yuan [1]. - The proportion of overseas revenue to total revenue for 2024 is 22.26% [1]. - The company has a diverse range of overseas customers across various regions, including Europe, America, and Asia [1]. Group 2: Product Segmentation - The products sold in overseas markets include minimally invasive vertebral body products, trauma or spinal orthopedic implants, and low-temperature radiofrequency (energy platform) products [1]. - There are significant differences in gross profit margins for different products across various regions [1].